AVM
QTTB icon

Arch Venture Management’s Q32 Bio QTTB Stock Holding History

Arch Venture Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-320,482
Closed -$2.06M – 13
2026
Q1 		$2.06M Hold
320,482
– – 0.3% 10
2025
Q4 		$1.06M Hold
320,482
– – 0.16% 9
2025
Q3 		$635K Hold
320,482
– – 0.13% 8
2025
Q2 		$478K Hold
320,482
– – 0.16% 9
2025
Q1 		$532K Hold
320,482
– – 0.26% 8
2024
Q4 		$1.1M Hold
320,482
– – 0.48% 7
2024
Q3 		$14.3M Hold
320,482
– – 5.49% 4
2024
Q2 		$5.75M Hold
320,482
– – 2.16% 6
2024
Q1 		$5.46M Buy
+320,482
New +$4.42M 6.8% 5

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Arch Venture Management's QTTB Position: Q2 2026 in Review

Arch Venture Management sold out of Q32 Bio (QTTB) in Q2 2026, closing a stake of 320,482 shares — an estimated $2.06M sold.

Arch Venture Management first reported a position in QTTB in Q1 2024 and held it in 9 quarters. The position peaked at $14.3M in Q3 2024. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Arch Venture Management reported no remaining Q32 Bio position as of Q2 2026 after selling out during the quarter.
  • Arch Venture Management sold 320,482 Q32 Bio shares in Q2 2026, an estimated $2.06M.
  • Arch Venture Management first reported a position in Q32 Bio in Q1 2024 and held it in 9 quarters.
  • Arch Venture Management's Q32 Bio position peaked at $14.3M in Q3 2024.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Arch Venture Management's 13F filing for Q2 2026, filed 14 Aug 2026.